Task: Answer Verification
Input (English): Question: Do measures in the first year of therapy predict the response to interferon beta in MS?
Answer: In RRMS patients treated with IFNbeta, the combination of measures of disease activity and the presence of new active lesions on MRI may have a prognostic value for identifying patients with disease activity in the second and third year of therapy.
Output (English): yes